Form N-CEN Stone Ridge Trust V For: Feb 28
Tweet
Share
E-mailX0303 N-CEN LIVE 0001658645 XXXXXXXX false false false N-2 Stone Ridge Trust V 811-23120 0001658645 549300KD54T7ZWXRKM31 510 Madison Avenue 21st Floor New York 10022 US-NY US 8556093680 Stone Ridge Trust V 510 Madison Avenue 21st Floor New York 10022 8336121912 Records related to its function as Registrant U.S. Bancorp Fund Services, LLC 615 E. Michigan St. Milwaukee 53202 8336121912 Records related to its function as Administrator ALPS Distributors Inc 1290 Broadway Suite 1000 Denver 80203 3036232577 Custodial books held U.S. Bank N.A. 615 E. Michigan St. Milwaukee 53202 8336121912 Records related to its function as Custodian Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York 10017 2124552000 Records related to its function as Independent Trustees Counsel Stone Ridge Asset Management LLC 510 Madison Avenue 21st Floor New York 10022 8336121912 Records related to its function as Adviser Millennium Trust Company, LLC 2001 Spring Road #700 Oak Brook 60523 6303685600 Records related to its function as Custodian N N N-2 Y Jeffery Ekberg N/A N Daniel Charney 002158255 N Ross Stevens N/A Y Lauren Macioce N/A 510 Madison Avenue 21st Floor New York 10022 XXXXXX N N N N N N Alps Distributors Inc 8-34626 000016853 N/A N N Ernst & Young, LLP 00042 254900H1VLSDPE6LJK37 N N N N N N Stone Ridge Alternative Lending Risk Premium Fund 549300KD54T7ZWXRKM31 N Interval Fund N N Y N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 23c-1 (17 CFR 270.23c-1) Rule 32a-4 (17 CFR 270.32a-4) Y Y Y N Stone Ridge Asset Management LLC 801-77228 000165598 549300JXJMSTRDTQF377 N U.S. Bancorp Fund Services, LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Duff & Phelps N/A N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N IHS Markit Ltd. 549300HLPTRASHS0E726 BM N N Millennium Trust Company N/A N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) U.S. Bank N.A. 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Wells Fargo Bank, N.A. KB1H1DSPRFMYMCUFXT09 N Y Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Barclays Bank Plc G5GSEF7VJP5I7OUK5573 GB N Y Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Commonwealth Bank of Australia MSFSBD3QN1GSN7Q6C537 AU N Y Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) ASB Bank Limited 549300IBZWZL1KTPF918 NZ N Y Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Stone Ridge Asset Management LLC 549300JXJMSTRDTQF377 Y N N U.S. Bancorp Fund Services, LLC N1GZ7BBF3NP8GI975H15 N N N 0.000000000000 U.S. BANCORP INVESTMENTS, INC. 8-35359-1 000017868 H85Z6XZP8B10ES0M2G89 4569535436.000000000000 Goldman Sachs & Co, LLC 8-00129 000000361 W22LROWP2IHZNBB6K528 437453658.000000000000 Upstart Network, Inc. N/A N/A N/A 245695040.000000000000 LendingClub Corporation N/A N/A N/A 148823544.000000000000 New York Life Insurance Company N/A N/A TAE73CY392TBWJ3O3305 89962033.000000000000 Robert W. Baird & Co. Incorporated 8-000497 000008158 549300772UJAHRD6LO53 108249448.000000000000 Zopa Limited N/A N/A N/A GB 101486489.000000000000 J.P. MORGAN SECURITIES LLC 8-35008-1 000000079 ZBUT11V806EZRVTWT807 99994444.000000000000 Upgrade N/A N/A N/A 80193091.000000000000 Square Capital, LLC N/A N/A N/A 65747710.000000000000 6156187926.000000000000 N 2487913678.302410000000 Common stock Common Shares N N Common stock N N N 0.015000000000 0.040400000000 N/A 57.090000000000 true
Report of Independent Registered Public Accounting Firm
To the Shareholders and
Board of Trustees of Stone Ridge Trust V
In planning and performing our audit of the financial statements of Stone Ridge Alternative Lending Risk Premium Fund
(the “Fund”) (the sole series constituting Stone Ridge Trust V) as of and for the year ended February 28, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund’s
internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of
Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.
The management of the Fund is responsible for establishing and maintaining effective internal control over financial
reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A fund’s internal control over financial reporting is a process designed to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. A fund’s internal control over financial
reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance
that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the fund are being made only in accordance with
authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial
statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may
deteriorate.
A deficiency in internal control over financial reporting exists when the design or operation of a control does not
allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over
financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis.
Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the
first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund’s internal control over financial
reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of February 28, 2021.
This report is intended solely for the information and use of management and the Board of Trustees of the Fund and
the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.
/s/ Ernst & Young LLP
Minneapolis, Minnesota
April 29, 2021
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Silicon Motion Announces Chief Financial Officer Transition
- The AI Summit London Announces Lord Holmes of Richmond MBE and NASA’s Christyl Johnson Taking the Stage 12 - 13 June
- Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
